دورية أكاديمية

The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial)

التفاصيل البيبلوغرافية
العنوان: The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial)
المؤلفون: Christian Daugaard Peters, Ole Norling Mathiassen, Henrik Vase, Jesper Bech Nørgaard, Kent Lodberg Christensen, Anne Pauline Schroeder, Hans Joachim von Hofe Rickers, Ulla Kampmann Opstrup, Per Løgstrup Poulsen, Sten Langfeldt, Gratien Andersen, Klavs Würgler Hansen, Hans Erik Bøtker, Morten Engholm, Jannik Buus Bertelsen, Erling Bjerregaard Pedersen, Anne Kaltoft, Niels Henrik Buus
المصدر: Blood Pressure, Vol 26, Iss 6, Pp 366-380 (2017)
بيانات النشر: Taylor & Francis Group, 2017.
سنة النشر: 2017
المجموعة: LCC:Diseases of the circulatory (Cardiovascular) system
مصطلحات موضوعية: renal denervation, randomized controlled trial, arterial stiffness, pulse wave velocity, central blood pressure, heart rate variability, Diseases of the circulatory (Cardiovascular) system, RC666-701
الوصف: Objectives: To investigate, whether renal denervation (RDN) improves arterial stiffness, central blood pressure (C-BP) and heart rate variability (HRV) in patients with treatment resistant hypertension. Methods: ReSET was a randomized, sham-controlled, double-blinded trial (NCT01459900). RDN was performed by a single experienced operator using the Medtronic unipolar Symplicity FlexTM catheter. C-BP, carotid-femoral pulse wave velocity (PWV), and HRV were obtained at baseline and after six months with the SphygmoCor®-device. Results: Fifty-three patients (77% of the ReSET-cohort) were included in this substudy. The groups were similar at baseline (SHAM/RDN): n = 27/n = 26; 78/65% males; age 59 ± 9/54 ± 8 years (mean ± SD); systolic brachial BP 158 ± 18/154 ± 17 mmHg; systolic 24-hour ambulatory BP 153 ± 14/151 ± 13 mmHg. Changes in PWV (0.1 ± 1.9 (SHAM) vs. −0.6 ± 1.3 (RDN) m/s), systolic C-BP (−2 ± 17 (SHAM) vs. −8 ± 16 (RDN) mmHg), diastolic C-BP (−2 ± 9 (SHAM) vs. −5 ± 9 (RDN) mmHg), and augmentation index (0.7 ± 7.0 (SHAM) vs. 1.0 ± 7.4 (RDN) %) were not significantly different after six months. Changes in HRV-parameters were also not significantly different. Baseline HRV or PWV did not predict BP-response after RDN. Conclusions: In a sham-controlled setting, there were no significant effects of RDN on arterial stiffness, C-BP and HRV. Thus, the idea of BP-independent effects of RDN on large arteries and cardiac autonomic activity is not supported.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 0803-7051
1651-1999
08037051
العلاقة: https://doaj.org/toc/0803-7051Test; https://doaj.org/toc/1651-1999Test
DOI: 10.1080/08037051.2017.1368368
الوصول الحر: https://doaj.org/article/7d24a772cee14ad5b1b88ae1cf830569Test
رقم الانضمام: edsdoj.7d24a772cee14ad5b1b88ae1cf830569
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:08037051
16511999
DOI:10.1080/08037051.2017.1368368